A Long-term, Randomized, Double-blind, Multicenter, Parallel-group, Phase III Study Evaluating the Efficacy and Safety of PT027 Compared to PT007 Administered as Needed in Response to Symptoms in Symptomatic Adults and Children 4 Years of Age or Older

    Project: Other project

    Project Details

    Effective start/end date7/22/197/21/21


    • Bond Avillion 2 Development LP: $9,961.53